MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Varenicline for Smoking Cessation in Heavy Drinking Smokers

Phase 2
Completed
Conditions
Smoking
Nicotine Dependence
Heavy Drinking
Interventions
First Posted Date
2009-03-11
Last Posted Date
2021-08-13
Lead Sponsor
Yale University
Target Recruit Count
30
Registration Number
NCT00860028

The Impact of Active Nurse Participation on Adenoma Detection During Routine Colonoscopy

Not Applicable
Completed
Conditions
Adenoma
Interventions
Procedure: nurse observation during colonoscope withdrawal
First Posted Date
2009-03-11
Last Posted Date
2015-01-22
Lead Sponsor
Yale University
Target Recruit Count
500
Registration Number
NCT00859625
Locations
🇺🇸

Yale-New Haven Hospital, New Haven, Connecticut, United States

Buprenorphine/Raltegravir Pharmacokinetic Interaction Study

Not Applicable
Completed
Conditions
HIV Infection
HIV Infections
Interventions
First Posted Date
2009-03-10
Last Posted Date
2012-11-21
Lead Sponsor
Yale University
Target Recruit Count
12
Registration Number
NCT00858962
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment

Completed
Conditions
HIV Positive
Opioid Dependence
Opioid Agonist Treatment
HIV Infections
First Posted Date
2009-03-06
Last Posted Date
2013-07-22
Lead Sponsor
Yale University
Target Recruit Count
60
Registration Number
NCT00857350
Locations
🇺🇸

Yale University Hospital, New Haven, Connecticut, United States

Changing Lifestyles for Better Health

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Behavioral: Intensive Lifestyle Intervention
First Posted Date
2009-02-20
Last Posted Date
2022-05-04
Lead Sponsor
Yale University
Target Recruit Count
130
Registration Number
NCT00848757
Locations
🇺🇸

Fair Haven Community Health Center, New Haven, Connecticut, United States

Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity

Phase 4
Terminated
Conditions
Pediatric Obesity
Insulin Resistance
Impaired Glucose Tolerance
Cardiovascular Disease
Interventions
First Posted Date
2009-02-18
Last Posted Date
2013-05-01
Lead Sponsor
Yale University
Target Recruit Count
23
Registration Number
NCT00846521
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults

Phase 4
Withdrawn
Conditions
Obesity
Cardiovascular Disease
Insulin Resistance
Impaired Glucose Tolerance
Interventions
First Posted Date
2009-02-18
Last Posted Date
2012-12-11
Lead Sponsor
Yale University
Registration Number
NCT00845559

Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma

Phase 2
Completed
Conditions
Hepatocellular Carcinoma
Hepatoma
Interventions
Procedure: LC Bead-TACE
First Posted Date
2009-02-16
Last Posted Date
2021-11-11
Lead Sponsor
Yale University
Target Recruit Count
50
Registration Number
NCT00844883
Locations
🇺🇸

The Johns Hopkins Hospital, Baltimore, Maryland, United States

Racial Differences in Orthostatic Tolerance

Completed
Conditions
Orthostatic Tolerance
First Posted Date
2009-02-16
Last Posted Date
2009-02-16
Lead Sponsor
Yale University
Target Recruit Count
18
Registration Number
NCT00844181
Locations
🇺🇸

John B. Pierce Laboratory, New Haven, Connecticut, United States

Dronabinol Interactions With Cognitive Enhancing Drug in Humans

Early Phase 1
Completed
Conditions
Cannabis
Marijuana Abuse
Interventions
Drug: drug condition
First Posted Date
2009-02-12
Last Posted Date
2017-05-30
Lead Sponsor
Yale University
Target Recruit Count
53
Registration Number
NCT00842985
Locations
🇺🇸

Department of Veterans Affairs Hospital, West Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath